Idiopathic anaphylaxis

Allergy and Asthma Proceedings

Volumn 35, Issue 1, 2014, Pages 17-23

  Lieberman, Phil L ^a  

^a University of Tennessee   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMITRIPTYLINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPHEDRINE; GALACTOSYLGALACTOSE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; KETOTIFEN; MONOAMINE OXIDASE INHIBITOR; OMALIZUMAB; PREDNISONE;

ANAPHYLAXIS; ARTICLE; DIAGNOSTIC TEST; DIFFERENTIAL DISPLAY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; IDIOPATHIC ANAPHYLAXIS; IDIOPATHIC DISEASE; IMMUNOPATHOLOGY; MAST CELL ACTIVATING SYNDROME; MORTALITY; NONHUMAN; PATHOGENESIS; QUALITY OF LIFE; RECURRENT DISEASE; RISK BENEFIT ANALYSIS; SENSITIZATION; SKIN TEST; SOMATOFORM DISORDER; SYMPTOMATOLOGY; SYSTEMIC MASTOCYTOSIS;

ANAPHYLAXIS; HUMANS;

EID: 84893411574     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2014.35.3717     Document Type: Article

References (89)

1. Bacal E, Patterson R, and Zeiss CR. Evaluation of severe (anaphylactic) reactions. Clin Allergy 8:295-304, 1978.
2. Lieberman P, and Taylor WW Jr. Recurrent idiopathic anaphylaxis. Arch Intern Med 139:1032-1034, 1979.
3. Blatman KH, and Ditto AM. Idiopathic anaphylaxis. Allergy Asthma Proc 33:S84 -S87, 2012.
4. Sale SR, Greenberger PA, and Patterson R. Idiopathic anaphylactoid reactions. A clinical summary. JAMA 246:2336 -2339, 1981.
5. Sheffer AL. Unraveling the mystery of idiopathic anaphylaxis. N Engl J Med 311:1248 -1249, 1984.
6. Wiggins CA, Dykewicz MS, and Patterson R. Idiopathic anaphylaxis: A review. Ann Allergy 62:1-4, 1989.
7. Wong S, Dykewicz MS, and Patterson R. Idiopathic anaphylaxis. A clinical summary of 175 patients. Arch Intern Med 150:1323-1328, 1990.
8. Wiggins CA, Dykewicz MS, and Patterson R. Idiopathic anaphylaxis: Classification, evaluation, and treatment of 123 patients. J Allergy Clin Immunol 82:849-855, 1988.
9. Wong S, Greenberger PA, and Patterson R. Nearly fatal idiopathic anaphylaxis reaction resulting in cardiovascular collapse and myocardial infarction. Chest 98:501-503, 1990.
10. Stoloff RS, Orfan N, Greenberger PA, et al. Malignant idiopathic anaphylaxis: Three additional cases and extended evaluation. Ann Allergy 69:37-42, 1992.
11. Kemp SF, Lockey RF, Wolf BL, and Lieberman P. Anaphylaxis: A review of 266 cases. Arch Intern Med 155:1749-1754, 1995.
12. Stoloff R, Adams SL, Orfan N, et al. Emergency medical recognition and management of idiopathic anaphylaxis. J Emerg Med 10:693-698, 1992.
13. Stoloff R, Patterson R. Harris KE, et al. Idiopathic anaphylaxis. Allergy Proc 14:135-136, 1993.
14. Patterson R, and Lieberman P. Idiopathic anaphylaxis: a purely internal reaction. Hosp Pract (1995) 31:47-51, 55-58, 64, 1996.
15. Krasnick J, Patterson R, and Harris KE. Idiopathic anaphylaxis: Long-term follow-up, cost, and outlook. Allergy 51:724-731, 1996.
16. Patterson R, Hogan MB, Yarnold PR, and Harris KE. Idiopathic anaphylaxis. An attempt to estimate the incidence in the United States. Arch Intern Med 155:869-871, 1995.
17. Ditto AM, Harris KE, Krasnick J, et al. Idiopathic anaphylaxis: A series of 335 cases. Ann Allergy Asthma Immunol 77:285-291, 1996.
18. Patterson R, Clayton DE, Booth BH, et al. Fatal and near fatal idiopathic anaphylaxis. Allergy Proc 16:103-108, 1995.
19. Mazur N, Patterson R, and Perlman D. A case of idiopathic anaphylaxis associated with respiratory infections. Ann Allergy Asthma Immunol 79:546-548, 1997.
20. Krasnick J, Patterson R, and Meyers GL. A fatality from idiopathic anaphylaxis. Ann Allergy Asthma Immunol 76:376-378, 1996.
21. Ditto AM, Krasnick J, Greenberger PA, et al. Pediatric idiopathic anaphylaxis: Experience with 22 patients. J Allergy Clin Immunol 100:320-326, 1997.
22. Hogan MB, Kelly MA, and Wilson NW. Idiopathic anaphylaxis in children. Ann Allergy Asthma Immunol 81:140-142, 1998.
23. Patterson R, and Harris KE. Idiopathic anaphylaxis. Allergy Asthma Proc 20:311-315, 1999.
24. Mastrovich JD, Patterson R, Davison R, and Harris KE. Using test dose challenges to restore essential therapy in patients with idiopathic anaphylaxis and pharmacophobia: Report of a patient with idiopathic anaphylaxis and statin phobia. Allergy Asthma Proc 22:303-309, 2001.
25. Lenchner KI, and Ditto AM. Idiopathic anaphylaxis. Allergy Asthma Proc 25(suppl 1):S54-S56, 2004.
26. Webb LM, and Lieberman P. Anaphylaxis: A review of 601. cases. Ann Allergy Asthma Immunol 97:39-43, 2006.
27. Greenberger PA. Idiopathic anaphylaxis. Immunol Allergy Clin North Am 27:273-293, 2007.
28. Lenchner K, and Grammer LC. A current review of idiopathic anaphylaxis. Curr Opin Allergy Clin Immunol 3:305-311, 2003.
29. Tejedor Alonso MA, Sastre DJ, Sanchez-Hernandez JJ, et al. Idiopathic anaphylaxis: A descriptive study of 81 patients in Spain. Ann Allergy Asthma Immunol 88:313-318, 2002.
30. Olalde Sánchez S, Feernandez VL, and Rodriguez Rodríguez J. Idiopathic anaphylaxis: Presentation of 4 cases. Rev Clin Esp 184:305-306, 1989.
31. Moneret-Vautrin DA. Idiopathic anaphylaxis. Eur Ann Allergy Clin Immunol 36:13-19, 2004.
32. Moneret-Vautrin DA, and Gay G. The so-called "idiopathic" anaphylaxis: Allergic and pseudo-allergic reactions. Allerg Immunol (Paris) 23:89-93, 1991.
33. Bourke J, Finucane J, and ÒLoughlin S. Idiopathic anaphylaxis. Ir Med J 90:62, 1997.
34. Ring J, and Darsow U. Idiopathic anaphylaxis. Curr Allergy Asthma Rep 2:40-45, 2002.
35. Geller M, and Geller P. Malignant idiopathic anaphylaxis does exist in Brazil. Ann Allergy Asthma Immunol 88:645, 2002.
36. Tanus T, Mines D, Atkins PC, and Levinson AI. Serum tryptase in idiopathic anaphylaxis: A case report and review of the literature. Ann Emerg Med 24:104-107, 1994.
37. Stricker WE, Anorve-Lopez E, and Reed CE. Food skin testing in patients with idiopathic anaphylaxis. J Allergy Clin Immunol 77:516-519, 1986.
38. Shanmugam G, Schwartz LB, and Khan DA. Prolonged elevation of serum tryptase in idiopathic anaphylaxis. J Allergy Clin Immunol 117:950-951, 2006.
39. Choy AC, Patterson R, Patterson DR, et al. Undifferentiated somatoform idiopathic anaphylaxis: nonorganic symptoms mimicking idiopathic anaphylaxis. J Allergy Clin Immunol 96: 893-900, 1995.
40. Hendrix S, Sale S, Zeiss CR, et al. Factitious Hymenoptera allergic emergency: A report of a new variant of Munchauseǹs syndrome. J Allergy Clin Immunol 67:8 -13, 1981.
41. Patterson R, Dykewicz MS, Grammer LC, et al. Classification of immediate-type, life-threatening allergic or pseudoallergic reactions. Chest 98:257-259, 1990.
42. Broom BC, and Fitzharris P. Life-threatening inhalant allergy: Typical anaphylaxis induced by inhalational allergen challenge in patients with idiopathic recurrent anaphylaxis. Clin Allergy 13:169-179, 1983.
43. Greenberger PA. Life-threatening idiopathic anaphylaxis associated with hyperimmunoglobulinemia E. Am J Med 76:553-556, 1984.
44. Saunders RL Jr, Halpern GM, and Gershwin ME. Odor-associated idiopathic anaphylaxis. A case report. Allergol Immunopathol (Madr) 23:35-37, 1995.
45. Choy AC, Patterson R, Patterson DR, et al. Undifferentiated somatoform idiopathic anaphylaxis: Nonorganic symptoms mimicking idiopathic anaphylaxis. J Allergy Clin Immunol 96: 893-900, 1995.
46. Patterson R, Tripathi A, Saltoun C, and Harris KE. Idiopathic anaphylaxis: Variants as diagnostic and therapeutic problems. Allergy Asthma Proc 21:141-144, 2000.
47. Patterson R. Idiopathic anaphylaxis. The evolution of a disease. Clin Rev Allergy Immunol 17:425-428, 1999.
48. Sanchez I, QuiñonesD, Rodriguez F, et al. Erroneous diagnosis of idiopathic anaphylaxis. Allergy 54:648-649, 1999.
49. Stoevesandt J, Grundmeier N, and Trautmann A. Gastroesophageal hymenoptera stings add to causes of idiopathic anaphylaxis. Ann Allergy Asthma Immunol 108:125-126, 2012.
50. Novembre E, Cianferoni A, Bernardini R, et al. Anaphylaxis in children: Clinical and allergologic features. Pediatrics 101:E8, 1998.
51. Gu len T, Gottberg L, Dahlén B, et al. Systemic mastocytosis. Underestimated condition in patients with idiopathic anaphylaxis. Lakartidningen 109:474-477, 2012.
52. Bobolea I, Guillén D, Barranco P, et al. Recurrent anaphylactic reactions: An uncommon debut of lymphocytic hypophysitis. Int Arch Allergy Immunol 159:103-106, 2012.
53. Picard M, Giavina-Bianchi P, Mezzano V, and Castells M. Expanding spectrum of mast cell activation disorders: Monoclonal and idiopathic mast cell activation syndromes. Clin Ther 35: 548-562, 2013.
54. Commins SP, James H, Tran N, et al. Testing for IgE antibody to the carbohydrate galactose-a-1, 3-galactose in patients with recurrent idiopathic anaphylaxis: How many cases are we missinǧ J Allergy Clin Immunol 125(suppl):AB119, 2010.
55. Reed J, Yedulapuram M, Lieberman P, et al. Differences in cytokine production between idiopathic anaphylaxis (IA) subjects and controls. J Allergy Clin Immunol 117:S305, 2006 (Abs).
56. Sonin L, and Patterson R. Metabisulfite challenge in patients with idiopathic anaphylaxis. J Allergy Clin Immunol 75:67-69, 1985.
57. Slater JE, and Kaliner M. Effects of sex hormones on basophil histamine release in recurrent idiopathic anaphylaxis. J Allergy Clin Immunol 80:285-290, 1987.
58. Orhan F, Canitez Y, Bakirtas A, et al. Anaphylaxis in Turkish children: A multi-centre, retrospective, case study. Clin Exp Allergy 41:1767-1776, 2011.
59. Slater JE, Raphael G, Cutler GB Jr, et al. Recurrent anaphylaxis in menstruating women: Treatment with a luteinizing hormone- releasing hormone agonist-A preliminary report. Obstet Gynecol 70:542-546, 1987.
60. Patterson R, Greenberger PA, Grammer LC, et al. Idiopathic anaphylaxis (IA): Suggested theories relative to the pathogenesis and response to therapy. Allergy Proc 14:365-367, 1993.
61. Grammer LC, Shaughnessy MA, Harris KE, and Goolsby CL. Lymphocyte subsets and activation markers in patients with acute episodes of idiopathic anaphylaxis. Ann Allergy Asthma Immunol 85:368-371, 2000.
62. Tejedor Alonso MA, Sastre Dominguez J, Sanchez-Hernandez JJ, et al. Clinical and functional differences among patients with idiopathic anaphylaxis. J Investig Allergol Clin Immunol 14: 177-186, 2004.
63. Tedeschi A, Lorini M, Suli C, and Cugno M. Detection of serum histamine-releasing factors in a patient with idiopathic anaphylaxis and multiple drug allergy syndrome. J Investig Allergol Clin Immunol 17:122-125, 2007.
64. Akin C, Scott LM, Kocabas CN, et al. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis. Blood 110:2331-2333, 2007.
65. Commins SP, and Platts-Mills TA. Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant. J Allergy Clin Immunol 124:652-657, 2009.
66. Patterson R, Greenberger PA, Orfan NA, and Stoloff RS. Idiopathic anaphylaxis: Diagnostic variants and the problem of nonorganic disease. Allergy Proc 13:133-137, 1992.
67. Orfan NA, Stoloff RS, Harris KE, and Patterson R. Idiopathic anaphylaxis: total experience with 225 patients. Allergy Proc 13:35-43, 1992.
68. Boxer MB, Greenberger PA, and Patterson R. The impact of prednisone in life-threatening idiopathic anaphylaxis: Reduction in acute episodes and medical costs. Ann Allergy 62:201-204, 1989.
69. Wiggins CA, Dykewicz MS, and Patterson R. Corticosteroiddependent idiopathic anaphylaxis: A report of five cases. J Allergy Clin Immunol 84:311-315, 1989.
70. Mehl A, Wahn U, and Niggemann B. Anaphylactic reactions in children-A questionnaire-based survey in Germany. Allergy 60:1440-1445, 2005.
71. Dykewicz MS, Wong SS, Patterson R, and Harris KE. Evaluation of ketotifen in corticosteroid-dependent idiopathic anaphylaxis. Ann Allergy 65:406-410, 1990.
72. Wong S, Yarnold PR, Yango C, et al. Outcome of prophylactic therapy for idiopathic anaphylaxis. Ann Intern Med 114:133-136, 1991.
73. Wong S, Patterson R, Harris KE, and Dykewicz MS. Efficacy of ketotifen in corticosteroid-dependent idiopathic anaphylaxis. Ann Allergy 67:359-364, 1991.
74. Patterson R, Fitzsimons EJ, Choy AC, and Harris KE. Malignant and corticosteroid-dependent idiopathic anaphylaxis: successful responses to ketotifen. Ann Allergy Asthma Immunol 79: 138-144, 1997.
75. Patterson R, and Greenberger PA. Problems in the management of idiopathic anaphylaxis. Allergy Asthma Proc 22:295-296, 2001.
76. Jones JD, Marney SR Jr, and Fahrenholz JM. Idiopathic anaphylaxis successfully treated with omalizumab. Ann Allergy Asthma Immunol 101:550-551, 2008.
77. Warrier P, and Casale TB. Omalizumab in idiopathic anaphylaxis. Ann Allergy Asthma Immunol 102:257-258, 2009.
78. Demirtu rk M, Gelincik A, Colakoǧ lu B, et al. Promising option in the prevention of idiopathic anaphylaxis: Omalizumab. J Dermatol 39:552-554, 2012.
79. Boxer M, Greenberger PA, and Patterson R. Clinical summary and course of idiopathic anaphylaxis in 73 patients. Arch Intern Med 147:269-272, 1987.
80. Valent P, Akin C, Arock M, et al. Definitions, criteria and global classifications of mast cell disorders with special reference to mast cell activation syndromes: A consensus proposal. Int Arch Allergy Immunol 157:215-225, 2012.
81. Khan DA, and Yocum MW. Clinical course of idiopathic anaphylaxis. Ann Allergy 73:370-374, 1994.
82. Horng HP, Metcalf DD, Bennet J, et al. Mastocytosis. In World Health Organization (WHO) Classification of Tumors of Hematopaetic and Lymphoid Tissues. 4th Edition. Swerdlow SH, Campo E, Harris NL (Eds). Lyon, France: IARC Press, 54-63, 2008.
83. Bonadonna P, Perbellini O, Passalacqua G, et al. Systemic reactions after hymenoptera sting and raised serum tryptase strongly suggest clonal mast cells disorders. J Allergy Clin Immunol 123(suppl): S242, 2009.
84. Ortolani C, Ispano M, Pastorello EA, et al. Comparison of results of skin prick tests (with fresh foods and commercial food extracts) and RAST in 100 patients with oral allergy syndrome. J Allergy Clin Immunol 83:683-690, 1989.
85. Jensen BM, Akin C, and Gilfillan AM. Pharmacological targeting of the KIT growth factor receptor: A therapeutic consideration for mast cell disorders. Br J Pharmacol 154:1572-1582, 2008.
86. Agarwala MK, George R, Mathews V, et al. Role of imatinib in the treatment of pediatric onset indolent systemic mastocytosis: A case report. J Dermatolog Treat 24:481- 483, 2013.
87. Keffer JM, Bressler RB, Wright R, et al. Analysis of the whealand- flare reactions that follow the intradermal injection of histamine and morphine in adults with recurrent, unexplained anaphylaxis and systemic mastocytosis. J Allergy Clin Immunol 83:595-601, 1989.
88. Valent P, Akin C, Arock M, et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: A consensus proposal. Int Arch Allergy Immunol 157:215-225, 2012.
89. Samant SA, Campbell RL, and Li JT. Anaphylaxis: Diagnostic criteria and epidemiology. Allergy Asthma Proc 34:115-119, 2013.